This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox.
Taking time off is nice, but returning for a July 4-shortened workweek is a bit discombobulating. Speaking of which, I’m landing in your inbox a day early because of the holiday. I hope you eat many hot dogs and watch amazing fireworks. Happy Birthday, America!
Let’s recap a wild week for Cassava Sciences
On Friday, the Justice Department charged the company’s chief scientific collaborator and paid consultant, Hoau-Yan Wang, with multiple counts of fraud. According to the indictment, Wang, a professor at City University of New York, fabricated and falsified data pertaining to Cassava’s drug for Alzheimer’s disease, called simufilam, in order to obtain $16 million in grants from the National Institutes of Health for himself and Cassava.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect